# StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects

> **NCT03005054** · PHASE2 · TERMINATED · sponsor: **Stratatech, a Mallinckrodt Company** · enrollment: 3 (actual)

## Conditions studied

- Trauma-related Wound
- Burns
- Skin Wound

## Interventions

- **BIOLOGICAL:** StrataGraft Skin Tissue
- **PROCEDURE:** Autograft

## Key facts

- **NCT ID:** NCT03005054
- **Lead sponsor:** Stratatech, a Mallinckrodt Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-24
- **Primary completion:** 2019-03-26
- **Final completion:** 2019-03-26
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Protracted enrollment and limited wound closure in the first three subjects
- **Last updated:** 2021-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03005054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03005054, "StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03005054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*